Top in cardiology: Keto-style diet and CVD risk; mortality risk in lifelong bachelors
Click Here to Manage Email Alerts
A low-carbohydrate, high-fat “keto-style diet” may increase cardiovascular risk in patients with certain traditional risk factors, according to a presenter at the American College of Cardiology Scientific Session.
Iulia Iatan, MD, PhD, FRCPC, postdoctoral fellow in cardiovascular disease prevention, clinical lipidology and cardiometabolic health at the Centre for Heart Lung Innovation at the University of British Columbia, said during her presentation that “despite the patients who report subjective improvements in their well-being during these diets, a known risk of the diets is that they may trigger or exacerbate hypercholesterolemia.”
It was the top story in cardiology last week.
Another top story was about the increased risk for mortality in men with heart failure who are lifelong bachelors.
Read these and more top stories in cardiology below:
‘Potential cardiovascular risk’ for some on keto-style diet
Certain traditional risk factors including severe high cholesterol, diabetes, hypertension and smoking may increase cardiovascular risk among those following a low-carbohydrate, high-fat “keto-style diet,” a speaker reported at the American College of Cardiology Scientific Session. Read more.
Lifelong bachelorhood tied to mortality in men with heart failure
Lifelong bachelor status was associated with elevated risk for mortality in men, but not women, with heart failure, researchers reported. Read more.
Eliminating copays for common heart, diabetes drugs does not improve CV outcomes
Eliminating monthly copays for 15 classes of common heart and diabetes medications did not improve clinical outcomes or reduce health care costs, despite a modest improvement in medication adherence, researchers reported. Read more.
Tailored EHR alert increases prescribing for recommended heart failure drug
An automated, patient-specific, electronic health record-embedded tool was associated with increased prescriptions of mineralocorticoid receptor antagonists for patients with heart failure, the BETTER CARE-HF study showed. Read more.
Return-to-play protocol ‘essential’ for elite athletes at risk for sudden cardiac death
Elite athletes with genetic risk for sudden cardiac death can safely return to play with a shared decision-making model that includes careful evaluation, risk stratification and tailoring of genetic heart disease therapy. Read more.